These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 10921025)
1. [Inhibition of apoptosis by bcr-abl fusion gene in K562 cells]. Wang C; Sun B; Yuan Y Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):340-1. PubMed ID: 10921025 [TBL] [Abstract][Full Text] [Related]
3. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells]. Wu Y; Chen Y; Hu J Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328 [TBL] [Abstract][Full Text] [Related]
4. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic effect of As2S2 on K562 cells and its mechanism. Li JE; Wu WL; Wang ZY; Sun GL Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474 [TBL] [Abstract][Full Text] [Related]
6. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference. Bártová E; Harnicarová A; Pacherník J; Kozubek S Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941 [TBL] [Abstract][Full Text] [Related]
7. [Study on the in vitro cleavage abilities of ribozymes specific to different sites of bcr-abl fusion gene and their induction of apoptosis in K562 cells]. Feng Q; Sun B; Zhao Y Zhonghua Yi Xue Za Zhi; 2000 Feb; 80(2):127-30. PubMed ID: 11798747 [TBL] [Abstract][Full Text] [Related]
8. [The effect of multi-unit ribozymes on the growth inhibition and apoptosis induction of CML K562 cells]. Feng Q; Sun B; Sun K; Shang Z; Wang S; Wang W; Zhao Y; Yan Z; Han W; Zhang Y Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):435-9. PubMed ID: 12485492 [TBL] [Abstract][Full Text] [Related]
9. [Effects of anti-ABL tyrosine kinase intrabody on the growth of K562 cells in nude mice]. Xu D; Song JM; Hu Y; Guo H; Cao DJ; Wang P; Liu H; Zhao CH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):11-4. PubMed ID: 12905832 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance. Pytel D; Wysocki T; Majsterek I Comp Biochem Physiol C Toxicol Pharmacol; 2006 Sep; 144(1):85-92. PubMed ID: 16904383 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells. Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828 [TBL] [Abstract][Full Text] [Related]
14. N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity. Lothstein L; Savranskaya L; Sweatman TW Leuk Res; 2007 Aug; 31(8):1085-95. PubMed ID: 17187856 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector. Sengupta A; Banerjee D; Chandra S; Banerjee S J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195 [TBL] [Abstract][Full Text] [Related]
16. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456 [TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression]. Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533 [TBL] [Abstract][Full Text] [Related]
20. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir. Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]